1. Home
  2. VERV vs BLZE Comparison

VERV vs BLZE Comparison

Compare VERV & BLZE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERV
  • BLZE
  • Stock Information
  • Founded
  • VERV 2018
  • BLZE 2007
  • Country
  • VERV United States
  • BLZE United States
  • Employees
  • VERV N/A
  • BLZE N/A
  • Industry
  • VERV Medicinal Chemicals and Botanical Products
  • BLZE Computer Software: Prepackaged Software
  • Sector
  • VERV Health Care
  • BLZE Technology
  • Exchange
  • VERV Nasdaq
  • BLZE Nasdaq
  • Market Cap
  • VERV 475.0M
  • BLZE 381.2M
  • IPO Year
  • VERV 2021
  • BLZE 2021
  • Fundamental
  • Price
  • VERV $7.28
  • BLZE $7.21
  • Analyst Decision
  • VERV Strong Buy
  • BLZE Strong Buy
  • Analyst Count
  • VERV 4
  • BLZE 4
  • Target Price
  • VERV $25.75
  • BLZE $11.50
  • AVG Volume (30 Days)
  • VERV 1.3M
  • BLZE 369.2K
  • Earning Date
  • VERV 02-28-2025
  • BLZE 02-25-2025
  • Dividend Yield
  • VERV N/A
  • BLZE N/A
  • EPS Growth
  • VERV N/A
  • BLZE N/A
  • EPS
  • VERV N/A
  • BLZE N/A
  • Revenue
  • VERV $24,396,000.00
  • BLZE $122,579,000.00
  • Revenue This Year
  • VERV $106.46
  • BLZE $27.53
  • Revenue Next Year
  • VERV N/A
  • BLZE $14.73
  • P/E Ratio
  • VERV N/A
  • BLZE N/A
  • Revenue Growth
  • VERV 219.91
  • BLZE 27.41
  • 52 Week Low
  • VERV $4.31
  • BLZE $4.91
  • 52 Week High
  • VERV $19.34
  • BLZE $12.65
  • Technical
  • Relative Strength Index (RSI)
  • VERV 47.08
  • BLZE 58.03
  • Support Level
  • VERV $7.44
  • BLZE $7.01
  • Resistance Level
  • VERV $9.31
  • BLZE $7.83
  • Average True Range (ATR)
  • VERV 0.67
  • BLZE 0.42
  • MACD
  • VERV -0.12
  • BLZE 0.06
  • Stochastic Oscillator
  • VERV 14.01
  • BLZE 70.19

About VERV Verve Therapeutics Inc.

Verve Therapeutics Inc is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. The company's initial two programs target PCSK9 and ANGPTL3, genes that have been extensively validated as targets for lowering blood lipids such as low-density lipoprotein cholesterol, a root cause of cardiovascular disease. The company views its operations as and manages its business in one operating segment operating exclusively in the United States.

About BLZE Backblaze Inc.

Backblaze Inc provides cloud storage services. The company offers services such as Backblaze B2 Cloud Storage which enables customers to store data, developers to build applications, and partners to expand their use cases. It is offered as a consumption-based Infrastructure-as-a-Service (IaaS) and serves use cases including backups, multi-cloud, application development, and ransomware protection and Backblaze Computer Backup automatically backs up data from laptops and desktops for businesses and individuals. Geographically, it derives a majority of revenue from the United States and the rest from the United Kingdom, Canada, and other regions.

Share on Social Networks: